FDA approves generic diabetes treatment for Impax

HAYWARD, Calif. - Impax Laboratories Inc. said Tuesday federal regulators have approved the company's application to make generic versions of the diabetes treatment Precose.

The U.S. Food and Drug Administration approved an abbreviated new drug application for 25-, 50- and 100-milligram strengths of the tablets. Impax expects to launch all strengths in the fourth quarter.

Impax said in a statement U.S. generic and branded sales of the drug, also known as acarbose, in those three... read more

Submitted by Avera

• 86 Views
• 0 Comments

Should You See a Dietitian or a Nutritionist?

Do any of the following sound familiar?

You’re trying to lose weight.
Your doctor told you your cholesterol is high and it needs to come down.
You found out you have diabetes, high blood pressure or cancer and you really need nutrition and diet information but don’t know where to turn.
You’ve had a heart attack and don’t want another one.
You’re tired of reading conflicting news stories about nutrition... read more

Submitted by Avera

• 249 Views
• 6 Comments

FDA Accepts MannKind’s Afresa Application

The FDA is now reviewing a new inhalable insulin product called Afresa from MannKind Corp.

They're seeking approval for use in Type 1 or Type 2 diabetics to control high blood sugar levels -- claiming that their proprietary Technosphere technology enables this fast-acting insulin to be absorbed more easily and safely.

Submitted by Amy Tenderich

• 181 Views
• 2 Comments

Under the radar

There's a new drug for type 2 diabetes, just approved by the FDA. Actually, it's an old drug, that has been approved for many years for other medical conditions, and which just got approval for treating diabetes.

I sort of stumbled across the news of its approval after a colleague sent out an e-mail (which indicated that he too was unaware of it until recently). With all the hullabaloo about several recent FDA reviews of... read more

Submitted by Avera

• 130 Views
• 3 Comments

Type 2 Diabetes Rears Its Ugly Head Long Before Diagnosis

Signs and symptoms of type 2 diabetes can present themselves as long as 10 years before diagnosis and most people have no idea before the damage is done.

Submitted by Avera

• 161 Views
• 1 Comment

Gene Therapy Shows Potential in Treating Diabetic Polyneuropathy

New gene therapy shows promise for improving symptoms of diabetic neuropathy -- including loss of sensation and pain in the legs and feet, weakness, and imbalance.

Submitted by Amy Tenderich

• 270 Views
• 1 Comment

Skip that post-workout smoothie....

... if it's loaded with antioxidants, that is. New research suggests that such vitamins can actually make exercise less beneficial than it otherwise would be, at least in terms of insulin sensitivity and thus the risk of diabetes.

Submitted by Amy Tenderich

• 126 Views
• 5 Comments

Pig-to-Monkey Transplant Treats Diabetes

By transplanting embryonic pancreatic tissue from pigs to monkeys, Israeli researchers report that they were able to reverse the primates' insulin deficiency. Important steps for the progress of transplantation techniques?

Submitted by Amy Tenderich

• 77 Views
• 0 Comments

Connections Between Diabetes And Alzheimer’s Disease Explored

ScienceDaily (May 11, 2009) — Modern societies face the increasing burden of age-related diseases, in particular Alzheimer’s disease (AD) and type 2 diabetes (T2D). There is some evidence that the causes underlying both diseases are linked. Do AD and T2D represent the endpoint of aged, exhausted, and dysfunctional cells having reached their maximal life expectancy or are AD and T2D the consequences of living in superabundance including excessive food supply, work demands, psychosocial stress, and... read more

Submitted by Avera

• 61 Views
• 0 Comments

Levemir(R) Once-Daily Substantially Lowered Average Blood Sugar Levels Of Patients With Type 2 Diabetes In TITRATE(R) Study

Novo Nordisk announced results from the TITRATE® study showing that Levemir® (insulin detemir [rDNA origin] injection), taken once-daily, substantially lowered average blood sugar. Type 2 diabetes patients took a more active role in their treatment by adjusting their own dosing, after being trained and given an adjustment schedule by their physician. Approximately 60 percent of patients taking Levemir® once-daily reached the American Diabetes Association's (ADA) recommended average blood sugar level.

Submitted by Avera

• 47 Views
• 0 Comments